SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-19-018153
Filing Date
2019-09-16
Accepted
2019-09-16 17:06:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b3091619_hoththera.htm 424B3 1158842
2 GRAPHIC img_001.jpg GRAPHIC 9162
3 GRAPHIC img_002.jpg GRAPHIC 84317
4 GRAPHIC img_003.jpg GRAPHIC 129647
5 GRAPHIC img_004.jpg GRAPHIC 46006
6 GRAPHIC img_005.jpg GRAPHIC 44192
7 GRAPHIC img_006.jpg GRAPHIC 104804
8 GRAPHIC img_007.jpg GRAPHIC 17902
9 GRAPHIC img_008.jpg GRAPHIC 54652
  Complete submission text file 0001213900-19-018153.txt   1836631
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-233563 | Film No.: 191095205
SIC: 2834 Pharmaceutical Preparations